about
Chikungunya Infection in Hospitalized Febrile Infants Younger Than 3 Months of AgeExternal ophthalmomyiasis caused by Dermatobia hominis. A retrospective study of nine cases and a review of the literatureKnowledge of free voluntary HIV testing centres and willingness to do a test among migrants in Cayenne, French Guiana.Staphylococcal Panton-Valentine leucocidin as a major virulence factor associated to furuncles.Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.Comparison of tetrazolium salt assays for evaluation of drug activity against Leishmania spp.HIV-associated histoplasmosis early mortality and incidence trends: from neglect to priority.Complex temporal climate signals drive the emergence of human water-borne diseaseT cell reactivity against mycolyl transferase antigen 85 of M. tuberculosis in HIV-TB coinfected subjects and in AIDS patients suffering from tuberculosis and nontuberculous mycobacterial infections.Use of PCR-restriction fragment length polymorphism analysis to identify the main new world Leishmania species and analyze their taxonomic properties and polymorphism by application of the assay to clinical samplesMolecular epidemiology of Leishmania (Viannia) guyanensis in French GuianaHistoplasmosis or tuberculosis in HIV-infected patients in the amazon: what should be treated first?Risk factors for delayed access to specialized care in French Guiana.Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampageHeterogeneity among Mycobacterium ulcerans from French Guiana revealed by multilocus variable number tandem repeat analysis (MLVA)Leishmaniavirus-Dependent Metastatic Leishmaniasis Is Prevented by Blocking IL-17A.Prevalence and Distribution of Leishmania RNA Virus 1 in Leishmania Parasites from French GuianaEpidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins.Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis.Predictive factors of HTLV1-HIV coinfections in French GuianaClimate and leishmaniasis in French Guiana.Predictive factors of herpes zoster HIV-infected patients: another adverse effect of crack cocaine.Primary prophylaxis of disseminated histoplasmosis in HIV patients in French Guiana: arguments for cost effectiveness.First detection of Mycobacterium ulcerans DNA in environmental samples from South AmericaRisk factors for disseminated histoplasmosis in a cohort of HIV-infected patients in French Guiana.How many have died from undiagnosed human immunodeficiency virus-associated histoplasmosis, a treatable disease? Time to act.Tuberculosis and histoplasmosis among human immunodeficiency virus-infected patients: a comparative study.Predictive factors of unprotected sex for female sex workers: first study in French Guiana, the French territory with the highest HIV prevalence.Cutaneous leishmaniasis in French Guiana: revising epidemiology with PCR-RFLP.[Leprosy in French Guyana: a retrospective study from 1997 to 2006]Unusual form of neurocysticercosis associated with HIV infection.Predictive values of prurigo nodularis and herpes zoster for HIV infection and immunosuppression requiring HAART in French Guiana.Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.IL-10 producing CD8+ T cells in human infection with Leishmania guyanensis.AIDS-related Histoplasma capsulatum var. capsulatum infection: 25 years experience of French Guiana.[Hookworm folliculitis in French Guiana].The use of structural equation modelling and behavioural theory to target priority interventions to increase condom use among the intimate partners of sex workers in French Guiana.HIV-1 Pol Gene Polymorphism and Antiretroviral Resistance Mutations in Treatment-Naive Adult Patients in French Guiana Between 2006 and 2012.Presence of Leishmania RNA Virus 1 in Leishmania guyanensis Increases the Risk of First-Line Treatment Failure and Symptomatic Relapse.[Paracoccidioidomycosis of the external ear].
P50
Q28223839-A117596E-2592-43C7-BD17-0714C4EE23E8Q28285120-28423D0D-343C-474D-B133-2B372DD743ABQ29353830-106AE407-A44B-4C5D-8288-0E7820623AFDQ30155449-1FA1EE57-86BC-44C9-84E8-C4CBA1035FD7Q33247311-88A3F2B2-FEA5-4260-BE26-771669EA4FBAQ33703500-8D690B2F-A304-4F4F-8FBC-9B5DA2536F3DQ34075154-DBCF7350-8435-47B8-8738-CB668B71A606Q34113600-0E238A4C-1193-450B-82E0-4F43875E2DD8Q34169888-437304BF-B427-49B2-94CD-41EA0BDE5434Q34430850-B5B1DDB0-308E-4DCF-A46E-19980274D4BBQ34430911-D544E9D2-9BF4-4B35-AE7D-8F083F62930CQ34633880-D9D23713-3BB7-4535-B52E-0099812954EEQ34875789-5975D790-1357-46FE-8AC3-EB289C765F31Q35054172-ADC36CD4-714E-4047-B84A-E5E3B3792A44Q35566003-5750C553-04FF-4E5D-B5FA-BF6419C9704AQ36141241-BAE49F3A-3A4F-4B72-A094-C2CC0111131BQ36455733-238187C8-7355-47F9-AB46-24E8891A0DC6Q36699080-E5F9B70B-B7EB-4854-8202-C2CA8CEED149Q37144991-A92B63C7-5E28-4E65-9997-FA7E21678C29Q37166166-F8C88796-1328-4D23-80CD-12C6E43994C6Q37166180-B47E15A5-CA03-4119-8B53-68CEF8793F4AQ37297444-E257F67A-6BEB-411E-9388-47E7E61B1381Q37372650-B375C1EB-0D52-4918-AE66-992B73D2A920Q37533805-DDA7C2EE-C401-4841-8B60-2F8BA22DD5ECQ37533899-B5591E9C-008D-4B44-8B66-0AE0B0341B9FQ37572867-86C556A9-4540-4667-9D2B-3C9C70EA6971Q37572882-49BF9799-5F55-4323-A983-828DF70FBAEBQ37578494-18CEAC88-239E-4D3E-ACDA-7C2F3F0D5656Q37673502-2FC18939-F2F1-449D-8599-EFB2CA7915F6Q38477077-34D83667-1FB2-465D-B305-DD7CFB006BDBQ38969524-C9D89B92-CDD4-477F-9E13-CB97435B6D81Q39202838-878D556A-0956-4979-B8F5-0F3AB5926670Q39203611-E0BA465C-14DB-42E5-A6DC-B003002CF045Q40124905-74E00321-6BE4-4C3D-9E3F-6241B09DA571Q40417716-82D8410F-8D68-40DF-8681-2B5123DDAC5BQ40612047-E8F60895-3854-4493-9F5F-7F2E2218B07AQ40650435-A2FFDBB9-C5EB-44DB-936E-BC0D567FC567Q40835857-0F4A7876-0556-404B-BED3-98B4D35C7235Q41132309-70E7255D-75A3-4CF7-818E-882F7800D147Q41744183-1162B0BB-016A-4682-81DD-A325D6B2DBF1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pierre Couppié
@ast
Pierre Couppié
@en
Pierre Couppié
@es
Pierre Couppié
@nl
Pierre Couppié
@sl
type
label
Pierre Couppié
@ast
Pierre Couppié
@en
Pierre Couppié
@es
Pierre Couppié
@nl
Pierre Couppié
@sl
prefLabel
Pierre Couppié
@ast
Pierre Couppié
@en
Pierre Couppié
@es
Pierre Couppié
@nl
Pierre Couppié
@sl
P106
P21
P31
P496
0000-0002-4213-2867